A nurse is caring for a client with bacterial meningitis who has been receiving IV antibiotics for 48 hours. The client's condition has stabilized, but the nurse notes new onset of bilateral hearing loss. What is the most appropriate nursing intervention?
The nurse is monitoring a 28-year-old client diagnosed with bacterial meningitis caused by Streptococcus pneumoniae who has been receiving high-dose IV ceftriaxone for 48 hours. Vital signs are stable, and neurological symptoms have improved significantly. However, during the morning assessment, the client reports difficulty hearing and asks the nurse to speak louder. Audiometry testing confirms bilateral sensorineural hearing loss.
1Stop the antibiotic immediately and notify the physician about the hearing loss
2Reduce the antibiotic dose by half and continue to monitor the client
3Document the findings, inform the physician, and continue the antibiotic while supporting the hearing loss✓ 정답
4Switch to an oral antibiotic and prepare the client for discharge home
해설
Ototoxicity is a known side effect of antibiotics like ceftriaxone, but discontinuing treatment prematurely can lead to treatment failure. The nurse should document findings, notify the physician, and continue the prescribed regimen while monitoring for complications.
The scenario describes a client with pneumococcal meningitis who has been on high-dose IV ceftriaxone for 48 hours. While the neurological symptoms are improving, a new onset of bilateral sensorineural hearing loss has been confirmed. The core clinical challenge is distinguishing between a complication of the disease itself and an adverse effect of the treatment, and then choosing the action that aligns with both patient safety and antimicrobial stewardship.
Pathophysiology and Clinical Reasoning
Hearing loss is a well-documented neurological complication of bacterial meningitis, occurring in up to 30% of cases. The primary mechanism is cochlear injury resulting from the spread of infection and inflammation from the meninges to the inner ear via the cochlear aqueduct or the internal auditory canal. This triggers a cascade of labyrinthitis involving oxidative stress, excitotoxicity, and direct damage to the hair cells of the organ of Corti, leading to permanent sensorineural hearing loss [4]. Critically, this damage often occurs during the acute phase of the infection, even when systemic symptoms are improving with appropriate antibiotics. The onset of hearing loss 48 hours into effective treatment is a classic presentation of a disease complication, not an ototoxic drug reaction.
Why the Other Options Are Incorrect
- Option 1 (Stop the antibiotic immediately): This is a dangerous action. Ceftriaxone is a beta-lactam antibiotic and is not known to be ototoxic. Discontinuing the life-saving treatment for bacterial meningitis prematurely, before the full course is completed, can lead to a relapse of the infection, increased neurological damage, and death. The hearing loss is a consequence of the infection, not the cure.
- Option 2 (Reduce the antibiotic dose): Reducing the dose of an antibiotic in a central nervous system infection is contraindicated. Achieving and maintaining bactericidal concentrations in the cerebrospinal fluid is essential for sterilization. Subtherapeutic dosing promotes treatment failure and the development of antibiotic resistance. This action would directly compromise the client's recovery.
- Option 4 (Switch to an oral antibiotic and prepare for discharge): Bacterial meningitis requires a prolonged course of high-dose intravenous antibiotics to penetrate the blood-brain barrier effectively. An oral antibiotic would not achieve the necessary CNS concentrations. Discharging the client at this stage would be premature and unsafe, as they are still in the acute treatment phase and have developed a significant new neurological deficit requiring multidisciplinary management.
The Correct Nursing Intervention
The most appropriate intervention is to document the findings, inform the physician, and continue the antibiotic while supporting the hearing loss. This approach correctly recognizes the hearing loss as a sequela of the meningitis rather than an adverse drug reaction. The nurse’s responsibilities are threefold:
1. Advocacy and Communication: Promptly informing the physician ensures the new deficit is formally diagnosed and that appropriate consultations, such as an otolaryngology and audiology referral, are initiated. This aligns with health systems analyses that highlight the need for integrated ear and hearing care pathways following acute illnesses .
2. Continuity of Care: Continuing the IV antibiotic without interruption is the single most important action to prevent further infectious complications. The treatment plan for the primary diagnosis must be maintained.
3. Supportive Care: The nurse must implement strategies to support the client’s new sensory deficit. This includes facing the client directly when speaking, reducing environmental noise, using clear articulation, and providing written information to ensure effective communication and reduce anxiety. This supportive care is initiated while the medical team determines the long-term management plan for the hearing loss [4].
References (research sources)
[4]
Hearing Loss in Young Adults: Risk Factors, Mechanisms and Prevention Models.Research articleFleser RC, Necula V, Ujvary LP, Osman A, Orasan A, Maniu AA. (2025) · DOI: 10.3390/biomedicines13123116
Managing New Neurological Deficits During Meningitis TreatmentDistinguishing Disease Complication from Drug Toxicity
New onset of sensorineural hearing loss during antibiotic therapy for bacterial meningitis is a complication of the infection, not an ototoxic drug reaction to beta-lactams like ceftriaxone. This damage often occurs in the acute phase despite clinical improvement.
The priority nursing intervention is to document the finding, notify the physician, and continue the prescribed IV antibiotic. Discontinuing or reducing the antibiotic risks treatment failure and worsening of the life-threatening CNS infection.
Caution
Never stop or reduce antibiotics for a suspected adverse effect without confirming the cause. Premature discontinuation in meningitis can be fatal. Focus care on supportive measures for the new deficit while maintaining the integrity of the treatment regimen.
Sensorineural Hearing Loss — Hearing loss caused by damage to the inner ear (cochlea) or the nerve pathways from the inner ear to the brain, a common sequela of bacterial meningitis.
Labyrinthitis — Inflammation of the inner ear or labyrinth, which can occur as a complication of meningitis when infection spreads via the cochlear aqueduct.
Antimicrobial Stewardship — A coordinated program that promotes the appropriate use of antimicrobials, including continuing effective therapy for a serious infection like meningitis.
Ceftriaxone — A third-generation cephalosporin antibiotic used to treat a wide variety of bacterial infections, including bacterial meningitis; ototoxicity is not a primary adverse effect.